Clinical Trials
28 trialsSPARTACUS
Icahn School of Medicine at Mount Sinai
SENTINEL
Abramson Cancer Center at Penn Medicine
CVE-CART
Abramson Cancer Center at Penn Medicine
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
DETECT
Assistance Publique - Hôpitaux de Paris
PROACT
Washington University School of Medicine
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
CLARITY
The Netherlands Cancer Institute
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Assiut University
Cardiovascular Function in Acute Leukemia
Abramson Cancer Center at Penn Medicine
LYMfit
Norwegian School of Sport Sciences
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
University of Nebraska
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
National Cheng-Kung University Hospital
CARTCO
University College London Hospitals
Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation
Chang Gung Memorial Hospital
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study
Insel Gruppe AG, University Hospital Bern
CONTROL
Humanitas Hospital, Italy
Cardiocare
A.O.U. Città della Salute e della Scienza
CAROLE
Northwell Health
Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin
Indiana University
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
Fudan University
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Children's Oncology Group
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Children's Oncology Group
Doxo
University Hospital Muenster
T-Cell #4
Children's Oncology Group